Drug Shortage Report for TOBI
| Report ID | 192953 |
| Drug Identification Number | 02239630 |
| Brand name | TOBI |
| Common or Proper name | TOBRAMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 AMPULES |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-06-01 |
| Actual start date | 2023-05-31 |
| Estimated end date | 2024-10-01 |
| Actual end date | 2024-05-31 |
| Shortage status | Resolved |
| Updated date | 2024-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v37 | 2024-04-29 | French | Compare |
| v36 | 2024-04-29 | English | Compare |
| v35 | 2024-04-16 | French | Compare |
| v34 | 2024-04-16 | English | Compare |
| v33 | 2024-03-25 | French | Compare |
| v32 | 2024-03-25 | English | Compare |
| v31 | 2024-03-12 | French | Compare |
| v30 | 2024-03-12 | English | Compare |
| v29 | 2024-02-21 | French | Compare |
| v28 | 2024-02-21 | English | Compare |
| v27 | 2024-02-15 | French | Compare |
| v26 | 2024-02-15 | English | Compare |
| v25 | 2024-01-22 | French | Compare |
| v24 | 2024-01-22 | English | Compare |
| v23 | 2023-12-19 | French | Compare |
| v22 | 2023-12-19 | English | Compare |
| v21 | 2023-12-12 | French | Compare |
| v20 | 2023-12-12 | English | Compare |
| v19 | 2023-11-06 | French | Compare |
| v18 | 2023-11-06 | English | Compare |